Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Qiagen
QGEN
$8.73B
| $9.11M | ﹤0.01% |
162,544
-390,075
| -71% | -$20.8M |
|
2652
CALL
PTC
PTC
$15.4B
| $9.1M | ﹤0.01% |
76,100
+17,800
| +31% | +$1.77M |
|
2653
Aldeyra Therapeutics
ALDX
$92.9M
| $9.09M | ﹤0.01% |
1,325,687
+296,868
| +29% | +$2.08M |
|
2654
PUT
Molina Healthcare
MOH
$10B
| $9.08M | ﹤0.01% |
42,700
-5,900
| -12% | -$1.22M |
|
2655
CALL
Vipshop
VIPS
$7.47B
| $9.06M | ﹤0.01% |
322,400
+144,900
| +82% | +$3.21M |
|
2656
CALL
HEICO Corp
HEI
$51.4B
| $9.04M | ﹤0.01% |
68,300
+42,900
| +169% | +$5.23M |
|
2657
Upbound Group
UPBD
$1.2B
| $9.04M | ﹤0.01% |
236,036
+88,558
| +60% | +$3.01M |
|
2658
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| $9.03M | ﹤0.01% |
+322,468
| New | +$9.02M |
|
2659
ICICI Bank
IBN
$109B
| $9.03M | ﹤0.01% |
607,591
+297,894
| +96% | +$3.74M |
|
|
LNFA.U
2660
DELISTED
L&F Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-half of one rede
LNFA.U
| $9.02M | ﹤0.01% |
+870,009
| New | +$8.87M |
|
2661
iShares Select Dividend ETF
DVY
$23.8B
| $9.02M | ﹤0.01% |
93,753
-48,210
| -34% | -$4.38M |
|
2662
Ares Management
ARES
$32.2B
| $9M | ﹤0.01% |
191,257
-486,166
| -72% | -$22M |
|
2663
PUT
Fastenal
FAST
$57.1B
| $8.99M | ﹤0.01% |
368,400
-50,400
| -12% | -$1.19M |
|
|
BBBY
2664
Bed Bath & Beyond
BBBY
$530M
| $8.99M | ﹤0.01% |
206,108
+84,799
| +70% | +$5.02M |
|
2665
Groupon
GRPN
$1.04B
| $8.99M | ﹤0.01% |
236,509
+96,038
| +68% | +$2.64M |
|
2666
iShares Core S&P Small-Cap ETF
IJR
$113B
| $8.98M | ﹤0.01% |
+97,768
| New | +$8.03M |
|
|
LHCG
2667
DELISTED
LHC Group LLC
LHCG
| $8.98M | ﹤0.01% |
42,096
+41,057
| +3,952% | +$8.74M |
|
2668
JPMorgan US Quality Factor ETF
JQUA
$8.48B
| $8.96M | ﹤0.01% |
249,802
+228,132
| +1,053% | +$7.81M |
|
2669
PUT
Nutanix
NTNX
$16.6B
| $8.96M | ﹤0.01% |
281,200
-116,500
| -29% | -$3.16M |
|
2670
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.08B
| $8.96M | ﹤0.01% |
+280,872
| New | +$8.41M |
|
2671
CALL
Williams Companies
WMB
$87.7B
| $8.96M | ﹤0.01% |
446,900
-291,700
| -39% | -$5.91M |
|
2672
Pulmonx
LUNG
$87M
| $8.96M | ﹤0.01% |
+129,745
| New | +$6.35M |
|
2673
PUT
GrowGeneration
GRWG
$89.5M
| $8.95M | ﹤0.01% |
222,600
+16,500
| +8% | +$444K |
|
|
RVNC
2674
PUT
DELISTED
Revance Therapeutics, Inc.
RVNC
| $8.94M | ﹤0.01% |
315,600
-300
| -0.1% | -$7.77K |
|
2675
CALL
Carlyle Group
CG
$18.3B
| $8.94M | ﹤0.01% |
284,200
-97,800
| -26% | -$2.75M |
|
Similar funds
Citadel Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.
- Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
- Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.